Victorian patients gain access to world-leading cancer detection technology | Alfred Health
Victorian cancer patients are set to benefit from groundbreaking advancements in medical technology, as The Alfred becomes the first public hospital in the state to introduce a revolutionary Total-Body Quadra PET scanner. This cutting-edge device is poised to revolutionize cancer care, diagnosis, and research, offering a myriad of advantages.
The Quadra PET scanner, housed within the Paula Fox Melanoma and Cancer Centre's Theranostics Service, is set to transform patient outcomes across Victoria. According to Prof. Mark Shackleton, Director of Oncology at The Alfred, this technology enables early cancer detection, even before symptoms manifest. This early detection can lead to more effective, safer, and personalized treatments, ultimately improving survival rates.
One of the key advantages of the Quadra is its ability to scan the entire body simultaneously, significantly reducing radiation exposure compared to traditional PET scans. This innovation makes scanning less daunting for patients and staff alike, especially those requiring multiple scans.
Moreover, the Quadra's capabilities extend beyond cancer care. Prof. Meng Law, Director of Radiology and Nuclear Medicine at The Alfred, highlights its potential in neurological research and treatment. The technology drastically reduces scan times from up to an hour to just five minutes, enabling the scanning of more patients in need with reduced discomfort.
The Quadra also opens new avenues in AI-driven diagnostics and precision medicine, positioning Victoria at the forefront of global innovation. Its ultra-high resolution and real-time technology empower clinicians and researchers to match therapies to individual tumour biology, a field known as theranostics. This enables the delivery of cutting-edge clinical trials and the ability to adjust treatments based on real-time patient responses.
Victorian Health Minister Mary-Anne Thomas visited the centre, witnessing the Quadra's capabilities firsthand. The scanner's implementation was made possible through a substantial $24 million investment, jointly funded by the Federal Government, Victorian Government, and philanthropic support from The Alfred Foundation.
In summary, the Quadra PET scanner marks a significant milestone in cancer care, offering earlier detection, safer scans, and personalized treatments. Its introduction at The Alfred is a testament to Victoria's commitment to leading the way in medical innovation and patient care.
